The present invention refers to novel compositions comprising hydroxytyrosol, resveratrol, lycopene, flavanols, and/or flavonoids and their use in treating and/or preventing pro-inflammatory diseases or disorders and ROS-mediated diseases or disorders. This invention also generally relates to compositions and to methods of using the compositions to increase tissue oxygenation.